AANPCB Family Nurse Practitioner (FNP) guideStudy & preparation
USPSTF Screening Recommendations for the AANPCB FNP Exam, From Newborn to Older Adult
Screening runs through NPCB's Assess domain and its health promotion knowledge area. The USPSTF screening ages, intervals and grades an FNP candidate should know, grouped by life stage, with the points where screening stops for older adults, as checked on October 28, 2026.
Short answer
NPCB's Assess domain includes ordering and interpreting screening tests, and its knowledge areas include disease prevention, but NPCB does not name a screening guideline. The USPSTF's grade A and B recommendations are the core set to know. Among them: blood pressure screening from 18, hepatitis C from 18 to 79, HIV from 15 to 65, diabetes screening from 35 to 70 with overweight or obesity, colorectal from 45 to 75, biennial mammography from 40 to 74, cervical screening from 21 to 65, lung CT from 50 to 80 for eligible current and former smokers, and osteoporosis screening for women 65 and older.
Where screening sits on the AANPCB FNP exam
Screening is not a separate section of NPCB's exam, but it runs through it. On NPCB's FNP certification page, one of the three Assess tasks is to "order, perform, and interpret screening and diagnostic tests," and Assess is the largest domain, with 43 of 135 scored items. One of the knowledge areas is "health promotion, harm reduction, and disease prevention."
NPCB does not say which screening guideline its items follow, and its reference list names textbooks rather than the U.S. Preventive Services Task Force. In Passy's view, the USPSTF is still the most useful single reference for primary care screening, because it grades the evidence for each population and publishes clear ages and intervals. Everything below comes from the USPSTF's own pages, as checked on October 28, 2026.
USPSTF grades in one line each
From the USPSTF's grade definitions:
| Grade | Meaning | What to do |
|---|---|---|
| A | Recommended, with high certainty of substantial net benefit | Offer or provide |
| B | Recommended: moderate net benefit with high certainty, or moderate to substantial net benefit with moderate certainty | Offer or provide |
| C | Small net benefit. Offer selectively, based on judgment and patient preference | Offer to selected patients |
| D | No net benefit, or harms outweigh benefits | Discourage |
| I | Evidence insufficient to assess benefits and harms | If offered, explain the uncertainty |
In a question, an A or B usually means "do it," a D means "don't," and a C means the answer turns on a shared decision with the patient.
USPSTF screening and prevention for children and adolescents
From the USPSTF's A and B list, with the release date of each current recommendation:
| Who | Recommendation | Grade | Current since |
|---|---|---|---|
| All newborns | Prophylactic ocular topical medication to prevent gonococcal ophthalmia neonatorum | A | January 2019 |
| Infants and children under 5 | Fluoride varnish on primary teeth from tooth eruption, and oral fluoride from 6 months if the water supply is deficient | B | December 2021 |
| Children aged 3 to 5 | Vision screening at least once, for amblyopia or its risk factors | B | September 2017 |
| Children and adolescents 6 and older with a BMI at or above the 95th percentile | Provide or refer to comprehensive, intensive behavioral interventions | B | June 2024 |
| Children and adolescents aged 8 to 18 | Screen for anxiety | B | October 2022 |
| Adolescents aged 12 to 18 | Screen for major depressive disorder | B | October 2022 |
| School-aged children and adolescents | Education or brief counseling to prevent tobacco use | B | April 2020 |
| Ages 6 months to 24 years with fair skin | Counseling to minimize ultraviolet exposure | B | March 2018 |
| From age 15 | HIV screening, and younger adolescents at increased risk | A | June 2019 |
| Sexually active adolescents | Behavioral counseling to prevent sexually transmitted infections | B | August 2020 |
USPSTF screening for adults 18 to 64
| Who | Recommendation | Grade | Current since |
|---|---|---|---|
| Adults 18 and older without known hypertension | Office blood pressure screening, confirmed outside the clinic before treatment starts | A | April 2021 |
| Adults, including pregnant and postpartum persons | Screen for depression | B | June 2023 |
| Adults 64 or younger, including pregnant and postpartum persons | Screen for anxiety disorders | B | June 2023 |
| Adults 18 and older | Screen for unhealthy alcohol use, with brief counseling for risky drinking | B | November 2018 |
| Adults 18 and older | Screen for unhealthy drug use by asking questions, not by testing specimens | B | June 2020 |
| Adults 18 to 79 | Screen for hepatitis C | B | March 2020 |
| Adolescents and adults 15 to 65 | Screen for HIV | A | June 2019 |
| Adults 35 to 70 with overweight or obesity | Screen for prediabetes and type 2 diabetes | B | August 2021 |
| Adults 45 to 49 / 50 to 75 | Screen for colorectal cancer | B / A | May 2021 |
| Women 40 to 74 | Mammography every 2 years | B | April 2024 |
| Women 21 to 65 | Cervical cancer screening (intervals below) | A | August 2018 |
| Adults 50 to 80 with a 20 pack-year history who smoke now or quit within 15 years | Annual low-dose CT for lung cancer | B | March 2021 |
| Sexually active women 24 and younger, and older women at increased risk | Screen for chlamydia and gonorrhea | B | September 2021 |
| Women of reproductive age, including pregnant and postpartum women | Screen for intimate partner violence | B | June 2025 |
| Women with a personal or family history of breast, ovarian, tubal or peritoneal cancer, or an ancestry linked to BRCA1/2 mutations | Brief familial risk assessment, then genetic counseling if positive, and genetic testing if indicated after counseling | B | August 2019 |
| Adolescents and adults at increased risk | Screen for hepatitis B | B | December 2020 |
| Persons at increased risk | Screen for syphilis | A | September 2022 |
| Adults at increased risk | Screen for latent tuberculosis infection | B | May 2023 |
For men aged 55 to 69, PSA-based prostate cancer screening is a C: an individual decision after discussing benefits and harms. The USPSTF's prostate page adds that clinicians should not screen men who do not express a preference for screening.
USPSTF screening in pregnancy and before conception
Prenatal care belongs to the adolescent, young adult and middle adult groups on NPCB's blueprint, so these items can appear at any of those ages.
| Who | Recommendation | Grade | Current since |
|---|---|---|---|
| Persons planning or able to become pregnant | Daily folic acid supplement of 0.4 to 0.8 mg (400 to 800 mcg) | A | August 2023 |
| All pregnant persons, at the first prenatal visit | Hepatitis B screening | A | July 2019 |
| All pregnant persons, including those in labor with unknown status | HIV screening | A | June 2019 |
| All pregnant persons, early, or at the first opportunity | Syphilis screening | A | May 2025 |
| All pregnant persons, at the first pregnancy-related visit | Rh(D) blood typing and antibody testing | A | February 2004 |
| Unsensitized Rh(D)-negative pregnant persons | Repeat Rh(D) antibody testing at 24 to 28 weeks, unless the biological father is known to be Rh(D)-negative | B | February 2004 |
| Pregnant persons | Urine culture for asymptomatic bacteriuria | B | September 2019 |
| Asymptomatic pregnant persons at 24 weeks or later | Screen for gestational diabetes | B | August 2021 |
| Pregnant persons | Blood pressure measurements throughout pregnancy for hypertensive disorders | B | September 2023 |
| Pregnant persons at high risk for preeclampsia | Low-dose aspirin (81 mg/day) after 12 weeks of gestation | B | September 2021 |
| Pregnant persons who use tobacco | Ask, advise to stop and provide behavioral interventions | A | January 2021 |
| Pregnant and postpartum persons at increased risk of perinatal depression | Provide or refer to counseling interventions | B | February 2019 |
| Pregnant persons | Behavioral counseling to promote healthy weight gain and prevent excess gestational weight gain | B | May 2021 |
| Pregnant and postpartum persons | Interventions or referrals to support breastfeeding | B | April 2025 |
For tobacco cessation in pregnancy, the USPSTF finds the evidence on pharmacotherapy insufficient, an I statement, so behavioral support is the graded recommendation.
Older adults: where screening starts, continues and stops
Older adults are NPCB's largest age group, with 40 of 135 scored items, and much of older-adult screening turns on an upper age limit or a stop rule.
| Topic | USPSTF recommendation | Grade |
|---|---|---|
| Abdominal aortic aneurysm | One-time ultrasonography for men 65 to 75 who have ever smoked. Selective for men 65 to 75 who never smoked (C). Not for women who never smoked and have no family history (D). Evidence insufficient for women 65 to 75 who have ever smoked or have a family history (I) | B |
| Osteoporosis | Screen women 65 and older, and postmenopausal women under 65 at increased fracture risk. Evidence insufficient for men (I) | B |
| Falls | Exercise interventions for community-dwelling adults 65 and older at increased risk of falls | B |
| Colorectal cancer, ages 76 to 85 | Offer selectively, based on overall health, prior screening and preferences | C |
| Breast cancer, 75 and older | Evidence insufficient to assess screening mammography | I |
| Cervical cancer, over 65 | Do not screen after adequate prior screening if not otherwise at high risk | D |
| Prostate cancer, 70 and older | Do not screen with PSA | D |
| Lung cancer | Annual low-dose CT through age 80 if eligible. Stop once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery | B |
| Hepatitis C | Screening recommendation ends at age 79 | B |
| Cognitive impairment | Evidence insufficient to assess screening in adults 65 and older. The USPSTF marks this topic as being updated | I |
The depression screening recommendation for adults explicitly includes older adults 65 and older (B, June 2023), while the anxiety screening recommendation covers adults 64 or younger. For quick recall of these cutoffs, flashcards on screening ages are planned for AANPCB FNP prep, alongside diagnostic criteria and first-line drugs.
USPSTF screening intervals worth memorizing
Intervals come straight from the USPSTF pages for each topic:
- Colorectal cancer, ages 45 to 75. High-sensitivity guaiac FOBT or FIT every year, stool DNA-FIT every 1 to 3 years, CT colonography every 5 years, flexible sigmoidoscopy every 5 years, flexible sigmoidoscopy every 10 years plus annual FIT, or colonoscopy every 10 years. An abnormal stool test, CT colonography or flexible sigmoidoscopy needs follow-up colonoscopy
- Cervical cancer. Ages 21 to 29: cytology every 3 years. Ages 30 to 65: cytology every 3 years, high-risk HPV testing alone every 5 years, or cotesting every 5 years. Not before 21, and not after a hysterectomy with removal of the cervix in people with no history of CIN 2 or 3 or cervical cancer
- Breast cancer. Mammography every 2 years from 40 to 74. The USPSTF finds the evidence insufficient on supplemental ultrasound or MRI for dense breasts after a negative mammogram
- Hypertension. The USPSTF suggests yearly screening from 40 and for adults at increased risk, and every 3 to 5 years for adults 18 to 39 who are not at increased risk and had a normal reading. Confirm a new diagnosis with ambulatory or home measurements before treating
- Lung cancer. Every year with low-dose CT while eligible
- Abdominal aortic aneurysm. Once
These facts belong to the Assess domain's test-ordering task, which is also the largest block of practice planned for full prep: 368 Assess questions are listed for AANPCB FNP prep at launch. The AANPCB FNP question breakdown shows an original Assess example on aneurysm screening.
Related preventive services that show up next to screening
These are preventive medications or counseling, not screening tests, but they sit on the same USPSTF list:
- Statins. Prescribe for adults 40 to 75 with at least one cardiovascular risk factor and a 10-year risk of 10% or higher (B, August 2022)
- HIV preexposure prophylaxis. Prescribe effective antiretroviral therapy for persons at increased risk of HIV (A, August 2023)
- Weight. Offer or refer adults with a BMI of 30 or higher to intensive, multicomponent behavioral interventions (B, September 2018)
- Tobacco cessation in nonpregnant adults. Ask, advise, and provide behavioral interventions and FDA-approved pharmacotherapy (A, January 2021)
- Diet and physical activity. Offer or refer adults with cardiovascular risk factors to behavioral counseling (B, November 2020)
- Breast cancer risk reduction. Offer to prescribe risk-reducing medications such as tamoxifen, raloxifene or aromatase inhibitors to women at increased risk for breast cancer and at low risk for adverse medication effects (B, September 2019)
Where the USPSTF stands in late 2026
As checked on October 28, 2026, the newest current recommendations on the USPSTF's A and B list date from 2025, such as intimate partner violence screening (June 2025), syphilis screening in pregnancy (May 2025) and breastfeeding support (April 2025). The Agency for Healthcare Research and Quality reports that the Task Force met on September 29 and 30, 2026, when eight new members joined and all 16 members were sworn in. The published recommendations above remain the current ones until the USPSTF replaces them, so check the A and B list again shortly before your exam.
Several topics in this guide are already being revised. On the USPSTF's Recommendations in Progress page, as checked on October 28, 2026, cervical cancer screening, perinatal depression prevention and unhealthy alcohol use screening are at the final stage, "Finalizing the Recommendation Statement." Prostate cancer screening, cognitive impairment screening, tobacco cessation in adults, tobacco prevention in children and adolescents, HIV screening, BRCA risk assessment, STI counseling, vision screening in young children and diet and physical activity counseling are at the earlier "Developing the Draft Recommendation Statement" stage. Draft wording is not a final recommendation, so learn the current statement and watch for the final one.
Two cautions for the exam itself. NPCB says its reference list is used in developing the exam, and a textbook can lag a guideline update, so for recently changed topics learn both the current rule and what changed. Breast cancer screening is one example: the 2024 recommendation replaced an individual decision for women in their 40s with biennial screening from 40. And other organizations publish their own screening guidance, which can differ from the USPSTF's. When a question names an organization, answer by that organization's rule.
Practicing screening questions for the AANPCB FNP exam
Screening facts stick when you apply them to a patient: age, sex, smoking history, pregnancy and prior results all change the answer. Try the 20 free AANPCB FNP practice questions, which include screening decisions such as autism screening at a well-child visit, and fit screening review into your weekly schedule with the free AANPCB FNP study planner. The AANPCB FNP knowledge areas guide covers the rest of the prevention topics NPCB lists.
When you want a larger set of screening questions, compare what each planned AANPCB FNP access period includes. Full prep is still being built, and checkout is not open.
Trust the source
Official sources
Exam policies can change. Use these primary sources for the most current details.
- A and B RecommendationsU.S. Preventive Services Task Force↗
- Grade DefinitionsU.S. Preventive Services Task Force↗
- Colorectal Cancer: Screening (final recommendation, May 2021)U.S. Preventive Services Task Force↗
- Breast Cancer: Screening (final recommendation, April 2024)U.S. Preventive Services Task Force↗
- Cervical Cancer: Screening (final recommendation, August 2018)U.S. Preventive Services Task Force↗
- Prostate Cancer: Screening (final recommendation, May 2018)U.S. Preventive Services Task Force↗
- Abdominal Aortic Aneurysm: Screening (final recommendation, December 2019)U.S. Preventive Services Task Force↗
- Osteoporosis to Prevent Fractures: Screening (final recommendation, January 2025)U.S. Preventive Services Task Force↗
- Lung Cancer: Screening (final recommendation, March 2021)U.S. Preventive Services Task Force↗
- Hypertension in Adults: Screening (final recommendation, April 2021)U.S. Preventive Services Task Force↗
- Cognitive Impairment in Older Adults: Screening (final recommendation, February 2020)U.S. Preventive Services Task Force↗
- USPSTF Welcomes New Members at Orientation and First MeetingAgency for Healthcare Research and Quality↗
- Recommendations in ProgressU.S. Preventive Services Task Force↗
- Family Nurse Practitioner (FNP) certification page: 2024 FNP Examination BlueprintNurse Practitioners Certification Board (AANPCB)↗
- FNP & AGNP Certification Examination Reference ListNurse Practitioners Certification Board (AANPCB)↗